Home/Filings/4/0001252491-13-000002
4//SEC Filing

OXYGEN BIOTHERAPEUTICS, INC. 4

Accession 0001252491-13-000002

$TENXCIK 0000034956operating

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 2:15 PM ET

Size

8.0 KB

Accession

0001252491-13-000002

Insider Transaction Report

Form 4
Period: 2013-07-23
Transactions
  • Purchase

    Common Stock Warrants (right to buy)

    2013-07-23+5,1295,129 total
    Exercise: $2.60From: 2013-07-23Exp: 2019-07-23common stock (5,129 underlying)
  • Purchase

    Series C 8% Convertible Preferred Stock

    2013-07-23+1010 total
    Exercise: $1.95From: 2013-07-23common stock (5,128 underlying)
Footnotes (2)
  • [F1]The Series C 8% Convertible Preferred Stock has no expiration date.
  • [F2]The reported securities are included within 25 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (1) a share of Series C 8% Convertible Preferred Stock which is convertible into approximately 512.82 shares of our common stock, and (2) one warrant exercisable for 512.82 shares of common stock at an exercise price of $2.60 per share.

Issuer

OXYGEN BIOTHERAPEUTICS, INC.

CIK 0000034956

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000034956

Filing Metadata

Form type
4
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 2:15 PM ET
Size
8.0 KB